HIV Clinical Trial
Official title:
Study of Epidermal Nerve Fiber Density, Subcutaneous Fat, and Mitochondrial Parameters in Thai HIV-positive Patients on Long-term Stavudine Treatment and in Thai HIV-negative Patients
This study will provide the range of Epidermal Nerve Fiber Density (ENFD) typically seen in Thai individuals. ENFD values from Thai HIV-negative subjects without neuropathy will be used as appropriate reference norm for Thai HIV-positive subjects. In particular, comparison of ENFD values from Thai HIV-negative subjects with baseline ENFD values in Thai HIV-positive subjects prior to highly active antiretroviral therapy (HAART) will allow examination of the effect of HIV per se on ENFD. ENFD from Thai HIV-positive subjects on long-term d4T (stavudine) with and without neuropathy will also provide reference ENFD values at the extremes of the disease process i.e. extent of ENFD decrease in subjects with d4T-induced symptomatic neuropathy and in subjects completely free of disease despite d4T treatment for comparison with Thai HIV-positive subjects on short-term d4T in SEARCH 003 study.
The range of changes in epidermal nerve fiber density (ENFD), subcutaneous fat, and
mitochondrial function induced by stavudine (d4T)-based therapy is currently not known,
globally or specifically in the Thai population. This study will evaluate ENFD and
subcutaneous fat and peripheral blood mitochondrial parameters in 4 groups of subjects.
Group 1 will include Thai HIV-positive subjects on long-term d4T treatment with symptomatic
peripheral neuropathy. Group 2 will include Thai HIV-positive subjects on long-term d4T
treatment without peripheral neuropathy. Group 3 will include HIV-negative subjects without
peripheral neuropathy.Group 4 will include Thai HIV-positive subjects on long-term d4T
treatment with asymptomatic peripheral neuropathy. Information gained from Thai HIV-positive
subjects on long-term d4T treatment with and without neuropathy in this study will provide
range of positive control values for subjects in the SEARCH 003 study and other studies
looking at the influence of antiretroviral agents on peripheral nerve, fat, and
mitochondria. Information gained from Thai HIV-negative subjects without neuropathy can be
used as negative control values for subjects in the SEARCH 003 study and other studies
looking at the influence of HIV or other diseases/pathogens on peripheral nerve, fat, and
mitochondria.
Hypothesis
1. HIV-positive patients who have been on long-term d4T treatment with symptomatic
peripheral neuropathy will have less ENFD, increased lipoatrophy, and altered
mitochondrial function than those on long-term d4T treatment with asymptomatic
peripheral neuropathy and those on long-term d4T treatment without peripheral
neuropathy.
2. HIV-negative patients without peripheral neuropathy will have more ENFD, no
lipoatrophy, and better mitochondrial function than HIV-positive patients.
The SEARCH 003 study will assess the extent of deterioration in ENFD induced by short-term
(from entry to 24 weeks) d4T use and the degree of improvement following discontinuation of
d4T (from week 24 to 72). However the range of changes in ENFD and in other mitochondrial
parameters induced by d4T-based therapy in not known, globally or specifically in the Thai
population.
This is a cross-sectional study that will enroll 25 HIV-positive subjects on long-term d4T
treatment with symptomatic peripheral neuropathy, 25 HIV-positive subjects on long-term d4T
treatment without peripheral neuropathy, 50 HIV-negative subjects without peripheral
neuropathy and 25 HIV-positive subjects on long-term d4T treatment with asymptomatic
peripheral neuropathy for a one-time assessment.
;
Observational Model: Case-Crossover, Time Perspective: Cross-Sectional
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT06162897 -
Case Management Dyad
|
N/A | |
| Completed |
NCT03999411 -
Smartphone Intervention for Smoking Cessation and Improving Adherence to Treatment Among HIV Patients
|
Phase 4 | |
| Completed |
NCT02528773 -
Efficacy of ART to Interrupt HIV Transmission Networks
|
||
| Active, not recruiting |
NCT05454839 -
Preferences for Services in a Patient's First Six Months on Antiretroviral Therapy for HIV in South Africa
|
||
| Recruiting |
NCT05322629 -
Stepped Care to Optimize PrEP Effectiveness in Pregnant and Postpartum Women
|
N/A | |
| Completed |
NCT02579135 -
Reducing HIV Risk Among Adolescents: Evaluating Project HEART
|
N/A | |
| Active, not recruiting |
NCT01790373 -
Evaluating a Youth-Focused Economic Empowerment Approach to HIV Treatment Adherence
|
N/A | |
| Not yet recruiting |
NCT06044792 -
The Influence of Primary HIV-1 Drug Resistance Mutations on Immune Reconstruction in PLWH
|
||
| Completed |
NCT04039217 -
Antiretroviral Therapy (ART) Persistence in Different Body Compartments in HIV Negative MSM
|
Phase 4 | |
| Active, not recruiting |
NCT04519970 -
Clinical Opportunities and Management to Exploit Biktarvy as Asynchronous Connection Key (COMEBACK)
|
N/A | |
| Completed |
NCT04124536 -
Combination Partner HIV Testing Strategies for HIV-positive and HIV-negative Pregnant Women
|
N/A | |
| Recruiting |
NCT05599581 -
Tu'Washindi RCT: Adolescent Girls in Kenya Taking Control of Their Health
|
N/A | |
| Active, not recruiting |
NCT04588883 -
Strengthening Families Living With HIV in Kenya
|
N/A | |
| Completed |
NCT02758093 -
Speed of Processing Training in Adults With HIV
|
N/A | |
| Completed |
NCT02500446 -
Dolutegravir Impact on Residual Replication
|
Phase 4 | |
| Completed |
NCT03805451 -
Life Steps for PrEP for Youth
|
N/A | |
| Active, not recruiting |
NCT03902431 -
Translating the ABCS Into HIV Care
|
N/A | |
| Completed |
NCT00729391 -
Women-Focused HIV Prevention in the Western Cape
|
Phase 2/Phase 3 | |
| Recruiting |
NCT05736588 -
Elimisha HPV (Human Papillomavirus)
|
N/A | |
| Recruiting |
NCT03589040 -
Darunavir and Rilpivirine Interactions With Etonogestrel Contraceptive Implant
|
Phase 2 |